These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 16611779)

  • 1. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.
    Boxerman JL; Schmainda KM; Weisskoff RM
    AJNR Am J Neuroradiol; 2006 Apr; 27(4):859-67. PubMed ID: 16611779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.
    Ding B; Ling HW; Chen KM; Jiang H; Zhu YB
    Neuroradiology; 2006 Oct; 48(10):773-81. PubMed ID: 16937146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
    Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
    Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
    AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
    Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
    AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Applying Leakage Correction on rCBV Measurement Derived From DSC-MRI in Enhancing and Nonenhancing Glioma.
    Arzanforoosh F; Croal PL; van Garderen KA; Smits M; Chappell MA; Warnert EAH
    Front Oncol; 2021; 11():648528. PubMed ID: 33869047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.
    Leu K; Boxerman JL; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    J Magn Reson Imaging; 2016 Nov; 44(5):1229-1237. PubMed ID: 26971534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
    Law M; Young R; Babb J; Pollack E; Johnson G
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading.
    Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH
    PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
    Saini J; Gupta RK; Kumar M; Singh A; Saha I; Santosh V; Beniwal M; Kandavel T; Cauteren MV
    PLoS One; 2019; 14(4):e0215400. PubMed ID: 31017934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
    Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
    Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
    Pillai JJ; Zacà D
    Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.